Atea Pharmaceuticals, Inc.
AVIR
Revenue
192.18M
▲159.37M▲485.72%
3 Months ChangeAssets
315.22M
▼-27.75M▼-8.09%
3 Months ChangeLiabilities
39.78M
▲12.60M▲46.36%
3 Months ChangeFree Cash Flow
-59.05M
▼-59.05M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001193125-26-093961
2026-01-08
Form 8-K
ID: 0001193125-26-007081
2025-11-12
Form 10-Q
ID: 0001193125-25-277815
2025-11-12
Form 8-K
ID: 0001193125-25-277627
2025-08-07
Form 10-Q
ID: 0000950170-25-105123
2025-08-07
Form 8-K
ID: 0001193125-25-175433
2025-06-20
Form 8-K
ID: 0001193125-25-143750
2025-05-12
Form 10-Q
ID: 0000950170-25-069367
2025-05-12
Form 8-K
ID: 0001193125-25-117809
2025-04-17
Form 8-K
ID: 0001193125-25-083523